Cosentyx Delivers Again For Novartis With Hidradenitis Suppurativa Launch

Two older drugs – Cosentyx and Entresto – continue to drive growth at the Swiss giant, while Leqvio is finally making its mark on the sales front.

Harry Kirsch
CFO Harry Kirsch • Source: Novartis

More from Earnings

More from Business